NCT05507606 2022-08-19
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
Clinical Trials
3 trialsNCT05273814 2022-07-13
Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Unknown
NCT03461185 2018-03-09
Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer
Xinqiao Hospital of Chongqing
Phase 2 Unknown